Implant Surfaces

Implant Surfaces is a U.S.-based medical device surface engineering company developing nano-engineered coatings and surface treatments for implantable devices and instruments. Its core offerings are designed to improve biocompatibility, tissue integration, and antimicrobial performance across orthopedic, spinal, dental, cardiovascular, and related device applications. The company markets the IntimateBond surface family to promote selective cell attachment, especially osteoblast attachment while limiting fibroblast interference, and is also developing Dual+ AgO antimicrobial surfaces for infection and biofilm control. Implant Surfaces positions itself as a platform technology supplier to device manufacturers rather than a therapeutic drug developer, with ISO 13485 certification and an FDA Master File referenced for IntimateBond.